𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists

✍ Scribed by Hu, Yanping; Gale, Matthew; Shields, Jacqueline; Garron, Carrie; Swistak, Mark; Nguyen, Tri-Hung; Jacques, Gary; Fogle, Robert; Siders, William; Kaplan, Johanne

Book ID
127184622
Publisher
Informa plc
Year
2011
Tongue
English
Weight
362 KB
Volume
53
Category
Article
ISSN
1042-8194

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-tumor activity of an anti-endoglin
Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice
✍ Masanori Tsujie; Tomoko Tsujie; Hirofumi Toi; Shima Uneda; Ken Shiozaki; Hilda T πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 221 KB

## Abstract In the present study, we investigated the mechanisms by which anti‐endoglin (EDG; CD105) monoclonal antibodies (mAbs) suppress angiogenesis and tumor growth. Antihuman EDG mAb SN6j specifically bound to murine endothelial cells and was internalized into the cells __in vitro__. SN6j effe

Enhanced clearance of radiolabeled murin
Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice
✍ Robert M. Sharkey; Otto C. Boerman; Ana Natale; David Pawlyk; Marc Monestier; Mi πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 945 KB

A syngeneic anti-idiotype monoclonal antibody (MAb) (CM-I I) directed against an anti-carcinoembryonic antigen (CEA) murine MAb (NP-4) was evaluated as a second antibody (SA) to promote the rapid clearance of radiolabeled NP-4 from the blood. Initial studies confirmed that CM-I I IgG removed l3Il-NP